ZFP42 maintains stemness and rhythmic transcription in human epidermal stem and progenitor cells via CRY1

TL;DR

ZFP42 helps maintain stem cell properties in human skin cells by regulating circadian rhythms and CRY1 expression.

Contribution

This study reveals a novel role for ZFP42 in linking circadian rhythms to stemness maintenance in epidermal stem cells.

Findings

Approximately 10% of expressed genes in human epidermal stem cells show rhythmicity.

ZFP42 knockdown reduces stemness and CRY1 expression, leading to decreased proliferation and increased differentiation.

ZFP42 is critical for circadian regulation of epidermal homeostasis and stem cell function.

Abstract

The role of circadian rhythm in regulating stemness in adult stem cells remains unclear. We investigated this in human epidermal stem and progenitor cells (EPSCs), finding that ~10% of expressed genes exhibit rhythmicity, with shared genes between fetal and adult EPSCs enriched in critical biological processes including the cell cycle, senescence, and apoptosis. Promoter motif analysis revealed ZFP42, a pluripotent stem cell marker, enriched in fetal rhythmic genes. ZFP42 knockdown led to the loss of stemness in human EPSCs and reduced expression of Cryptochrome Circadian Regulator 1 (CRY1), a core component of the molecular circadian clock that functions as a transcriptional repressor within the CLOCK-BMAL1 feedback loop, resulting in decreased cell proliferation and increased differentiation gene expression. These results highlight the critical role of ZFP42 in the circadian regulation of epidermal homeostasis, linking stemness maintenance to circadian mechanisms. Our findings deepen the understanding of how circadian rhythms govern epidermal stem cell functions.

Circadian rhythms shape epidermal stem cell fate by regulating rhythmic gene expression in human EPSCs. ZFP42 maintains stemness by sustaining CRY1 expression, promoting proliferation and restraining differentiation to preserve epidermal homeostasis.

Figures